{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:52:13Z","timestamp":1762444333464},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2012,10,21]],"date-time":"2012-10-21T00:00:00Z","timestamp":1350777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11046-012-9593-0","type":"journal-article","created":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T15:17:53Z","timestamp":1350746273000},"page":"91-98","source":"Crossref","is-referenced-by-count":8,"title":["Pseudomembranous Candidiasis in HIV\/AIDS Patients in Cali, Colombia"],"prefix":"10.1007","volume":"175","author":[{"given":"Luz \u00c1ngela","family":"Castro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda In\u00e9s","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,21]]},"reference":[{"key":"9593_CR1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.25100\/cm.v39i4.616","volume":"39","author":"EM Pinz\u00f3n","year":"2008","unstructured":"Pinz\u00f3n EM, Bravo SM, M\u00e9ndez F, Clavijo GM, Le\u00f3n ME. Prevalencia y factores relacionados con la presencia de manifestaciones orales en pacientes con VIH\/SIDA, Cali, Colombia. Colomb Med. 2008;39:346\u201355.","journal-title":"Colomb Med"},{"issue":"Suppl","key":"9593_CR2","first-page":"153","volume":"9","author":"JM Aguirre-Ur\u00edzar","year":"2004","unstructured":"Aguirre-Ur\u00edzar JM, Echebarr\u00eda-Goicour\u00eda MA, Egu\u00eda-del-Valle A. Acquired immunodeficiency syndrome: manifestations in the oral cavity. Med Oral Patol Oral Cir Bucal. 2004;9(Suppl):153\u20137.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"9593_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.otc.2010.09.010","volume":"44","author":"PJ Giannini","year":"2011","unstructured":"Giannini PJ, Shetty KV. Diagnosis and management of oral candidiasis. Otolaryngol Clin North Am. 2011;44:231\u201340.","journal-title":"Otolaryngol Clin North Am"},{"key":"9593_CR4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.qai.0000225729.79610.b7","volume":"42","author":"CB Holmes","year":"2006","unstructured":"Holmes CB, Wood R, Badri M, Zilber S, Wang B, Maartens G, et al. CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr. 2006;42:464\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9593_CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/157016208786501445","volume":"6","author":"H Egusa","year":"2008","unstructured":"Egusa H, Soysa NS, Ellepola AN, Yatani H, Samaranayake LP. Oral candidosis in HIV-infected patients. Curr HIV Res. 2008;6:485\u201399.","journal-title":"Curr HIV Res"},{"key":"9593_CR6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00001432-200112000-00002","volume":"14","author":"SW Redding","year":"2001","unstructured":"Redding SW. The role of yeasts other than Candida albicans in oropharyngeal candidiasis. Curr Opin Infect Dis. 2001;14:673\u20137.","journal-title":"Curr Opin Infect Dis"},{"key":"9593_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4103\/0019-5154.57622","volume":"54","author":"VP Baradkar","year":"2009","unstructured":"Baradkar VP, Kumar S. Species identification of Candida isolates obtained from oral lesions of HIV infected patients. Indian J Dermatol. 2009;54:385\u20136.","journal-title":"Indian J Dermatol"},{"key":"9593_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1590\/S0074-02762002000200019","volume":"97","author":"P Sant\u2019Ana","year":"2002","unstructured":"Sant\u2019Ana P, Milan EP, Martinez R, Queiroz-Telles F, Ferreira MS, Alc\u00e2ntara AP, et al. Multicenter Brazilian study of oral Candida species isolated from AIDS patients. Mem Inst Oswaldo Cruz. 2002;97:253\u20137.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9593_CR9","first-page":"492","volume":"39","author":"SD Nadagir","year":"2008","unstructured":"Nadagir SD, Chunchanur SK, Halesh LH, Yasmeen K, Chandrasekhar MR, Patil BS. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients. Southeast Asian J TropMed Public Health. 2008;39:492\u20135.","journal-title":"Southeast Asian J TropMed Public Health"},{"key":"9593_CR10","doi-asserted-by":"crossref","unstructured":"Masi\u00e1 Canuto M, Guti\u00e9rrez Rodero F, Ortiz de la Tabla Ducasse V, Hern\u00e1ndez Aguado I, Mart\u00edn Gonz\u00e1lez C, S\u00e1nchez Sevillano A, et al. Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2000;19:593\u2013601.","DOI":"10.1007\/s100960000323"},{"key":"9593_CR11","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1086\/320517","volume":"32","author":"S Walmsley","year":"2001","unstructured":"Walmsley S, King S, McGeer A, Ye Y, Richardson S. Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression. Clin Infect Dis. 2001;32:1554\u201361.","journal-title":"Clin Infect Dis"},{"key":"9593_CR12","first-page":"183","volume":"11","author":"C Guti\u00e9rrez","year":"2007","unstructured":"Guti\u00e9rrez C, de Bedout C, Tob\u00f3n AM, Cano LE, Arango M, Tabares AM, et al. Sensibilidad a fluconazol y voriconazol de aislamiento de Candida spp., obtenidos de aislamientos de mucosa oral de pacientes con sida. Infectio. 2007;11:183\u20139.","journal-title":"Infectio"},{"key":"9593_CR13","doi-asserted-by":"crossref","unstructured":"Mendoza N, Arora A, Motta A, Arias C. Prevalence of oral candidiasis in the HAART era in developing countries: A cohort from Colombia. J Am Acad Dermatol. 2008; 58 S2 AB94.","DOI":"10.1016\/j.jaad.2007.10.419"},{"key":"9593_CR14","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1128\/JCM.40.12.4768-4770.2002","volume":"40","author":"DR Hospenthal","year":"2002","unstructured":"Hospenthal DR, Murray CK, Beckius ML, Green JA, Dooley DP. Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium. J Clin Microbiol. 2002;40:4768\u201370.","journal-title":"J Clin Microbiol"},{"key":"9593_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11046-008-9145-9","volume":"167","author":"MI \u00c1lvarez","year":"2009","unstructured":"\u00c1lvarez MI, Su\u00e1rez BL, Caicedo LD. Isolation of Candida dubliniensis for the first time in Cali, Colombia, and its identification with phenotyping methods. Mycopathologia. 2009;167:19\u201324.","journal-title":"Mycopathologia"},{"key":"9593_CR16","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1128\/JCM.37.12.3804-3808.1999","volume":"37","author":"AC Gales","year":"1999","unstructured":"Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and \u03b1-methyl-D-glucoside as determined with the API 20C AUX and Vitek YBC systems. J Clin Microbiol. 1999;37:3804\u20138.","journal-title":"J Clin Microbiol"},{"key":"9593_CR17","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; 3rd Informational Supplement, M27\u2013S3","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; 3rd Informational Supplement, M27\u2013S3. Wayne PA: Clinical and Laboratory Standards Institute; 2008."},{"key":"9593_CR18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","volume":"13","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A. CLSI subcommittee for antifungal susceptibility testing. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat. 2010;13:180\u201395.","journal-title":"Drug Resist Updat"},{"key":"9593_CR19","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1128\/JCM.05047-11","volume":"49","author":"MA Pfaller","year":"2011","unstructured":"Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Jones RN. Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida. J Clin Microbiol. 2011;49:3800\u20134.","journal-title":"J Clin Microbiol"},{"key":"9593_CR20","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.00248-12","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA, Espinel-Ingroff A, Canton E, Castanheira M, Cuenca-Estrella M, Diekema DJ, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J Clin Microbiol. 2012;50:2040\u20136.","journal-title":"J Clin Microbiol"},{"key":"9593_CR21","first-page":"836","volume":"131","author":"A Mane","year":"2010","unstructured":"Mane A, Panchvalli S, Bembalkar S, Risbud A. Species distribution & antifungal susceptibility of oral Candida colonising or infecting HIV infected individuals. Indian J Med Res. 2010;131:836\u20138.","journal-title":"Indian J Med Res"},{"key":"9593_CR22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1439-0507.2004.01019.x","volume":"47","author":"AM Schmidt-Westhausen","year":"2004","unstructured":"Schmidt-Westhausen AM, Bendick C, Reichart PA, Samaranayake LP. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics. Mycoses. 2004;47:435\u201341.","journal-title":"Mycoses"},{"key":"9593_CR23","first-page":"177","volume":"40","author":"J Maninder","year":"2008","unstructured":"Maninder J, Usha A. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients. J Commun Dis. 2008;40:177\u201381.","journal-title":"J Commun Dis"},{"key":"9593_CR24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0255-0857.49442","volume":"27","author":"U Arora","year":"2009","unstructured":"Arora U, Jagdev M, Jindal N. Immunosuppression level in HIV-positive patients with oropharyngeal candidiasis. Indian J Med Microbiol. 2009;27:174\u20135.","journal-title":"Indian J Med Microbiol"},{"key":"9593_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1007237711099","volume":"149","author":"S Magaldi","year":"2001","unstructured":"Magaldi S, Mata S, Hartung C, Verde G, Deibis L, Rold\u00e1n Y, et al. In vitro susceptibility of 137 Candida sp. isolates from HIV positive patients to several antifungal drugs. Mycopathologia. 2001;149:63\u20138.","journal-title":"Mycopathologia"},{"key":"9593_CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1258\/004947506776593404","volume":"36","author":"E Gupta","year":"2006","unstructured":"Gupta E, Vajpayee M, Xess I, Seth P. Oral candidiasis in HIV-infected patients and its relation to CD4\u00a0+\u00a0counts: an adjunct clinical marker of HIV disease progression. Trop Doct. 2006;36:127.","journal-title":"Trop Doct"},{"key":"9593_CR27","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Woosley LN, Messer SA, Jones RN, Castanheira M. Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme. Mycopathologia. 2012 May 13. [Epub ahead of print].","DOI":"10.1007\/s11046-012-9551-x"},{"key":"9593_CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11046-010-9286-5","volume":"169","author":"ES Loreto","year":"2010","unstructured":"Loreto ES, Scheid LA, Nogueira CW, Zeni G, Santurio JM, Alves SH. Candida dubliniensis: epidemiology and phenotypic methods for identification. Mycopathologia. 2010;169:431\u201343.","journal-title":"Mycopathologia"},{"key":"9593_CR29","first-page":"14","volume":"14","author":"W Delgado","year":"1997","unstructured":"Delgado W, Aguirre JM. Las micosis orales en la era del sida. Rev Iberoam Micol. 1997;14:14\u201322.","journal-title":"Rev Iberoam Micol"},{"key":"9593_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/154405910708600304","volume":"86","author":"L Li","year":"2007","unstructured":"Li L, Redding S, Dongari-Bagtzoglou A. Candida glabrata: an emerging oral opportunistic pathogen. J Dent Res. 2007;86:204\u201315.","journal-title":"J Dent Res"},{"key":"9593_CR31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1754-4505.2000.tb00015.x","volume":"20","author":"SW Redding","year":"2000","unstructured":"Redding SW, Kirkpatrick WR, Dib O, Fothergill AW, Rinaldi MG, Patterson TF. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients. Spec Care Dentist. 2000;20:178\u201381.","journal-title":"Spec Care Dentist"},{"key":"9593_CR32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/1040841X.2010.489506","volume":"36","author":"LY Chai","year":"2010","unstructured":"Chai LY, Denning DW, Warn P. Candida tropicalis in human disease. Crit Rev Microbiol. 2010;36:282\u201398.","journal-title":"Crit Rev Microbiol"},{"key":"9593_CR33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF01691310","volume":"15","author":"F Dronda","year":"1996","unstructured":"Dronda F, Alonso-Sanz M, Laguna F, Chaves F, Mart\u00ednez-Su\u00e1rez JV, Rodr\u00edguez-Tudela JL, et al. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 1996;15:446\u201352.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9593_CR34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tripleo.2003.09.008","volume":"97","author":"SW Redding","year":"2004","unstructured":"Redding SW, Dahiya MC, Kirkpatrick WR, Coco BJ, Patterson TF, Fothergill AW, et al. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2004;97:47\u201352.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"key":"9593_CR35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2334\/josnusd.53.203","volume":"53","author":"AS Bodhade","year":"2011","unstructured":"Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci. 2011;53:203\u201311.","journal-title":"J Oral Sci"},{"key":"9593_CR36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tripleo.2009.11.026","volume":"109","author":"GR Thompson","year":"2010","unstructured":"Thompson GR, Patel PK, Kirkpatrick WR, Westbrook SD, Berg D, Erlandsen J, et al. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:488\u201395.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"9593_CR37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2180-8-135","volume":"8","author":"OJ Hamza","year":"2008","unstructured":"Hamza OJ, Matee MI, Moshi MJ, Simon EN, Mugusi F, Mikx FH, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol. 2008;8:135.","journal-title":"BMC Microbiol"},{"key":"9593_CR38","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/AAC.38.7.1530","volume":"38","author":"F Barchiesi","year":"1994","unstructured":"Barchiesi F, Colombo AL, McGough DA, Forhergill AW, Rinaldi MG. In vitro activity of itraconazole against fluconazole-susceptible and\u2014resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Agents Chemother. 1994;38:1530\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"9593_CR39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1099\/jmm.0.013227-0","volume":"59","author":"RJ Kothavade","year":"2010","unstructured":"Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol. 2010;59:873\u201380.","journal-title":"J Med Microbiol"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-012-9593-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-012-9593-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-012-9593-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T11:47:02Z","timestamp":1643543222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-012-9593-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,21]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9593"],"URL":"https:\/\/doi.org\/10.1007\/s11046-012-9593-0","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,21]]}}}